Platt OS: Hydroxyurea for the treatment of sickle cell disease, N Engl J Med 358:1362, 2008. [A review focused on the beneficial effects of hydroxyurea in sickle cell disease.]
Wassmer SC, Taylor TE, Rathod PK, et al: Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach, Am J Trop Med Hyg 93(Suppl):42, 2015. [A review of the proposed pathophysiology of severe forms of malaria.]
Wong TE, Brandow AM, Lim W, et al: Update on the use of hydroxy-urea therapy in sickle cell disease, Blood 124:3850, 2014. [A review focused on the beneficial effects of hydroxyurea in sickle cell disease.]
Young NS, Bacigalupo A, Marsh JC: Aplastic anemia: pathophysiology and treatment, Biol Blood Marrow Transplant 16:S119, 2010. [Discussion of the role of the immune system and telomerase mutations in aplastic anemia.]
Anderson KC, Carrasco RD: Pathogenesis of myeloma, Annu Rev Pathol 6:249, 2011. [A review of advances in understanding the molecular pathogenesis of multiple myeloma.]
Arber DA, Orazi A, Hasserjian R, et al: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood 127:2391, 2016. [A report providing the rationale for revision of the WHO classification of myeloid neoplasms.] http://ebooksmedicine.net
Inaba H, Greaves M, Mullighan CG: Acute lymphoblastic leukemia, Lancet 381:1943, 2013. [A review of the pathogenesis, diagnosis, and treatment of ALL.]
Mathas S, Hartmann S, Kuppers R: Hodgkin lymphoma: Pathology and biology, Semin Hematol 53:139, 2016. [A concise review of Hodgkin lymphoma pathogenesis.]
Swerdlow SH, Campo E, Pileri SA, et al: The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood 127:2375, 2016. [An overview of the most recent WHO classification of lymphoid neoplasms.]
The Cancer Genome Atlas Research Network: Genomic and epigenomic networks landscapes in adult de novo acute myeloid leukemia, N Engl J Med 368:2059, 2013. [Landmark paper that uses next-generation sequencing and other genome-wide approaches to systematically describe genomic alterations in AML.]
Young RM, Staudt LM: Targeting pathological B cell receptor signaling in lymphoid malignancies, Nat Rev Drug Discov 12:229, 2013. [An excellent review of the role of B cell receptor signaling in non-Hodgkin lymphoma and its potential as a therapeutic target.]
Arepally GM, Ortel TL: Heparin-induced thrombocytopenia, Annu Rev Med 61:77, 2010. [A discussion of pathogenesis, clinical features, diagnostic criteria, and therapeutic approaches in HIT.]
Ng C, Motto DG, Di Paola J: Diagnostic approach to von Willebrand disease, Blood 125:2029, 2015. [A review on the molecular pathogenesis and diagnosis of vWD.]